|
業務類別
|
Biotechnology |
|
業務概覽
|
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. Ithas one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies. |
| 公司地址
| 150 Union Square Drive, New Hope, PA, USA, 18938 |
| 電話號碼
| +1 215 862-5797 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.orchestrabiomed.com |
| 員工數量
| 86 |
| Mr. David P. Hochman |
Chairman of the Board and Chief Executive Officer |
美元 595.00K |
12/03/2026 |
| Mr. Joshua Aiello |
Corporate Controller and Principal Accounting Officer |
-- |
12/03/2026 |
| Mr. Darren R. Sherman |
President, Chief Operating Officer and Director |
美元 495.00K |
12/03/2026 |
| Mr. Andrew L. Taylor |
Chief Financial Officer |
美元 395.00K |
12/03/2026 |
|
|
| Mr. David P. Hochman |
Chairman of the Board and Chief Executive Officer |
12/03/2026 |
| Mr. Jason M. Aryeh |
Independent Director |
12/03/2026 |
| Ms. Pamela Ann Connealy, M.B.A. |
Independent Director |
12/03/2026 |
| Mr. David C. Pacitti |
Independent Director |
12/03/2026 |
| Mr. Darren R. Sherman |
President, Chief Operating Officer and Director |
12/03/2026 |
| Mr. Eric S. Fain,M.D. |
Lead Independent Director |
12/03/2026 |
| Mr. Christopher Cleary |
Independent Director |
12/03/2026 |
| Mr. John Mack |
Independent Director |
12/03/2026 |
|
|
|
|
